0 likes | 5 Vues
This report highlights the top 10 life sciences trends for 2025, focusing on obesity treatment breakthroughs, antibody-drug conjugates (ADCs) projected to hit $40B by 2030, and rapid advancements in cell and gene therapies. Biosimilars will see significant growth, while AI-driven innovations could add $410B annually. Direct-to-Consumer (DTC) and Direct-to-Patient (DTP) models will transform healthcare access. Pharma companies will shift to value-based models, reshape launch strategies, and increase M&A activities. Real-World Evidence (RWE) will drive better decision-making, enhancing drug deve
E N D